Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-11-25

Clinical Trial Update: A Study of Luffa Operculate Nasal Solution 5mg/mL Compared With Saline (NaCl 09%) for the Relief of Nasal Obstruction [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update describes a study comparing Luffa operculate nasal solution 5 mg/mL to saline for relief of nasal obstruction in rhinitis and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Luffa Operculate Nasal Solution 5mg/mL (Luffa operculate nasal solution)

Snippet

Sponsor: Zurita Laboratorio Farmaceutico Ltda. | Conditions: Rhinitis, Sinusitis | Phase 3 | Status: UNKNOWN